WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹887 Cr | ₹617 Cr | ₹-22 Cr | ₹261 Cr | ₹496 Cr |
What is the latest Total Non-Current Liabilities ratio of WOCKHARDT ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹887 Cr |
| Mar2024 | ₹617 Cr |
| Mar2023 | ₹-22 Cr |
| Mar2022 | ₹261 Cr |
| Mar2021 | ₹496 Cr |
How is Total Non-Current Liabilities of WOCKHARDT Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹887 Cr | 43.76 | |
| Mar2024 | ₹617 Cr | Positive | |
| Mar2023 | ₹-22 Cr | Negative | |
| Mar2022 | ₹261 Cr | -47.38 | |
| Mar2021 | ₹496 Cr | - | |
Compare Total Non-Current Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹21,943.2 Cr | -0.8% | -0.2% | 6.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -6.8% | -7.6% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,357.0 Cr | -6.6% | -5.8% | 4.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | 0.9% | 5.7% | 27.3% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.8% | -8.1% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2% | -8.8% | -12.9% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -0.8% |
-0.2% |
6.1% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses